Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fas (CD95/Apo-1) mutations were previously reported as the genetic defect responsible for human lymphoproliferative syndrome associated with autoimmune manifestations (also known as autoimmune lymphoproliferative syndrome or Canale-Smith syndrome). We have identified 14 new heterozygous Fas mutations. Analysis of patients and families allow us to further dissect this syndrome with regards to the relationship between Fas mutations, inheritance pattern, and phenotype as observed on long-term follow-up. In vitro studies show that lymphocytes from all Fas mutant carriers exhibit a Fas-antibody-induced apoptosis defect. However, among the 8 inherited mutations, 4 of 4 Fas missense mutations were associated with high clinical penetrance, whereas 3 of 4 mutations leading to a truncated Fas product were associated with variable clinical penetrance. This suggests that a second defect, in another yet undefined factor involved in apoptosis and/or lymphoproliferation control, is necessary to induce full clinical expression of the disease. These results also indicate that the currently available antibody-mediated in vitro apoptosis assay does not necessarily reflect the in vivo ability of abnormal Fas molecules to trigger lymphocyte death. In addition, we found that lymphoproliferative manifestations resolved with age, whereas immunological disorders [ie, hypergammaglobulinemia and detection of TcR alphabeta(+) CD4(-) CD8(-) lymphocytes] persisted. This observation suggests that Fas-mediated apoptosis plays a more important role in lymphocyte homeostasis in early childhood than later on in life.

Type

Journal article

Journal

Blood

Publication Date

10/1999

Volume

94

Pages

2575 - 2582

Addresses

Department of Pediatric Immunology, Unit INSERM U429, Hôpital Necker-Enfants-Malades, Paris, France. rieux@necker.fr

Keywords

T-Lymphocytes, Humans, Uveitis, Hypergammaglobulinemia, Lymphoproliferative Disorders, Hypersplenism, Autoimmune Diseases, Splenomegaly, Genetic Predisposition to Disease, Splenectomy, Follow-Up Studies, Amino Acid Substitution, Age Factors, Apoptosis, Heterozygote, Genes, Dominant, Genetic Heterogeneity, Point Mutation, Exons, Adolescent, Adult, Child, Infant, Female, Male, fas Receptor